Tube Investments Boosts Pharma Arm With ₹100 Crore Investment

Investment Details

Tube Investments of India Limited (TII) announced on April 23, 2026, that it signed an agreement to invest an additional ₹75 crore into its subsidiary, 3xper Innoventure Limited. Co-investor Mr. N. Govindarajan will contribute ₹25 crore, bringing the total capital infusion to ₹100 crore.

This funding will be provided through Compulsorily Convertible Preference Shares (CCPS) and is earmarked for scaling up 3xper's pharmaceutical contract development and manufacturing operations.

Strategic Diversification

This significant capital injection is a key step in TII's strategy to diversify its business interests beyond its traditional engineering and manufacturing domains. It reinforces TII's presence in the high-growth pharmaceutical contract development and manufacturing organization (CDMO) segment, aiming to accelerate 3xper's expansion and enhance its capabilities for global clients.

Background: 3xper Innoventure's Genesis

TII first entered the pharmaceutical CDMO sector in March 2023 with the establishment of 3xper Innoventure. At that time, TII had planned a total investment of up to ₹285 crore, with Mr. N. Govindarajan expected to contribute up to ₹15 crore. 3xper Innoventure, incorporated in May 2023, operates as a CDMO providing end-to-end services for drug discovery, development, and manufacturing. The current ₹100 crore investment represents a renewed commitment to the subsidiary's growth path.

Impact of the Funding

The new capital will be crucial for 3xper Innoventure to expand its infrastructure, upgrade technology, and broaden its service offerings. This expansion is expected to bolster 3xper's capacity to handle larger projects and attract a more diverse client base within the global pharmaceutical industry.

Key Risks and Considerations

The completion of this transaction is subject to the satisfactory fulfillment of certain conditions precedent, as detailed in the Supplementary Agreement. In separate news, TII was recently notified of a ₹41,400 penalty from GST authorities in August 2024. While noted, this penalty is considered minor and is not expected to materially affect the company's operations.

Market Context and Peers

Tube Investments of India Ltd. operates across various sectors, including automotive components, engineering, and bicycles, with notable peers such as Bosch Ltd., UNO Minda Ltd., and Samvardhana Motherson International Ltd. Within the CDMO space, 3xper Innoventure's direct competitors are primarily global players, as the listed CDMO market in India is still in its early stages of development.

Looking Ahead

Investors will be watching for the successful finalization of the investment, contingent on the agreed conditions precedent. Key tracking points will include the progress of 3xper Innoventure's scaling initiatives, its growing contribution to TII's overall revenue and profit diversification, and any future announcements regarding significant client wins or capacity expansions.